Preview

Rational Pharmacotherapy in Cardiology

Advanced search

QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIAL

https://doi.org/10.20996/1819-6446-2012-8-2-154-157

Full Text:

Abstract

Aim. To study changes in quality of life (QoL) in patients with atrial fibrillation (AF) treated with warfarin after leaving the international clinical trial. Material and Methods. Patients with AF who were managed at cardiology department of the University Hospital participated in the study. Patients of the main group (n=79) completed the international clinical trial with warfarin titration to therapeutic doses and subsequent therapy monitoring at least 1 year . Patients of the control group (n=23) had never taken part in clinical trials. QoL was evaluated with the 36-Item Short-Form Health Survey (SF 36) questionnaire after international clinical trial living or hospital discharge (initially) and in 3, 6 months of follow-up in outpatient clinic. Results. The most significant changes were observed in the first 3 months. In patients of the main group after clinical trial leaving physical component of QoL decreased from 65 (52.0-77.0) to 52 (25.0–55.0) points (p<0.05) and emotional component – from 65 (55.0-70.0) to 60 (50.0–65.0) points (p<0.05). At the same period opposite dynamics was observed in patients of the control group after hospital discharge. Physical component of QoL increased from 55 (25.0-65.0) to 65 (52.0–77.0) points (p<0.05) and emotional component - from 60 (47.5- 65.0) to 70 (60.0–75.0) points (p<0.05). In the next 3 months QoL levels have not changed significantly in patients of the both groups. Conclusion. International clinical trial living affects QoL in patients with AF . The physical component of QoL worsens most significantly.

About the Authors

E. L. Artanova
Saratov State Medical University named after V.I. Razumovsky
Russian Federation


L. E. Kon'shina
Saratov State Medical University named after V.I. Razumovsky
Russian Federation


I. M. Sokolov
Saratov State Medical University named after V.I. Razumovsky
Russian Federation


Y. G. Shvarts
Saratov State Medical University named after V.I. Razumovsky
Russian Federation


References

1. Arkad'eva G.V ., Radzevich A.Je., Sedov A.N. Prevention and treatment of thrombosis and thromboembolism by anticoagulants at cardiovascular pathology. Rossijskij kardiologicheskij Zhurnal 2007;3(65):86-96. Russian (Аркадьева Г .В., Радзевич А.Э., Седов А.Н. Профилактика и лечение тромбозов и тромбоэмболий антикоагулянтами при сердечно-сосудистой патологии. Российский кардиологический журнал 2007;3(65):86-96).

2. Clinical studies in Russia. Orange Book. I quarter of 2011. Available at: http://rusbiont.ru/assets/files/ob2011.pdf. Date of access 12/18/2011. Russian (Клинические исследования в России. Оранжевая книга. I квартал 2011 года. Доступно на: http://rusbiont.ru/assets/files/ob2011.pdf. Дата обращения 18.12.2011).

3. Platonov P . Clinical trials in Russia and Eastern Europe: Recruitment and quality. Int J Clin Pharmacol Therapeut 2003; 41(7): 277-280 (Платонов П.А. Клинические испытания в России и Восточной Европе: набор и качество. Международный журнал по клинической фармакологии и терапии 2003; 41(7): 277-280).

4. Semernin E.N., Shlyakhto E.V., Kozlova S.N., Miroshenkov P .V. Quality of life related to health: theory, methods, practices. Kachestvennaya klinicheskaya praktika 2001; 2: 48-52. Russian (Семернин Е.Н., Шляхто Е.В., Козлова С.Н., Мирошенков П.В. Качество жизни, связанное со здоровьем: теория, методы практика. Качественная клиническая практика 2001; 2: 48-52).

5. Lüderitz B., Jung W. Quality of life in atrial fibrillation. J Interv Card Electrophysiol 2000; 4 Suppl: 201- 209.

6. Mant JW, Richards SH, Hobbs FR et al. Protocol for the Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population (ISRCTN 89345269). BMC Cardiovasc Disord 2003; 3: 9

7. Das AK, Willcoxson PD, Corrado OJ. Does long-term warfarin affect the quality of life of older people? Age and Ageing 34(3): 312-313.

8. Das AK, Willcoxson PD, Corrado OJ, West RM. The impact of long-term warfarin on the quality of life of elderly people with atrial fibrillation. Age and Ageing 2007; 36 (1): 95-97.


For citation:


Artanova E.L., Kon'shina L.E., Sokolov I.M., Shvarts Y.G. QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIAL. Rational Pharmacotherapy in Cardiology. 2012;8(2):154-157. (In Russ.) https://doi.org/10.20996/1819-6446-2012-8-2-154-157

Views: 472


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)